Naldi, L.

patient psoriasis treatment therapy study evidence dermatol ciclosporin effect guideline efalizumab table disease methotrexate response infection dermatology grade combination plaque psoriasis infliximab european psoriasis vulgaris efficacy pasi 75 response vulgari reaction result author adalimumab phototherapy etanercept level 12 weeks suppl trial safety liver jeadv group academy venereology compilation journal increase 5–70 venereology guidelines pregnancy improvement plaque side effects pasi /bsa arthritis venereology pathirana arthritis symptom interaction acitretin malignancy measure © 2009 reduction contraindication retinoid serum quality exposure assessment erythema blood 5 mg /kg randomized alefacept drug reactions induction therapy pasi 75 placebo hepatitis tuberculosis fumaric acid esters recommendation